Morgan Stanley Reiterates Overweight on Eli Lilly (LLY), Cites Growth Potential of New Platform
Corroborated by 2 sources from 2 publishers
TL;DR
Reports differ across sources; according to finance.yahoo.com, pixabay/Public Domain In order to produce solutions that enhance employee access to obesity management medications, the platform facilitates collaboration with independent program administrators.
Sources
1
Investing.com News
https://www.investing.com/news/analyst-ratings/morgan-stanley-cuts-teleperformance-stock-rating-on-weak-growth-outlook-93CH-4576660
2
Investing.com News
https://www.investing.com/news/analyst-ratings/morgan-stanley-initiates-generate-biomedicines-stock-at-overweight-93CH-4576732
3
Investing.com News
https://www.investing.com/news/stock-market-news/morgan-stanley-turns-bullish-on-thyssenkrupp-after-30-slide-4576853
4
Investing.com News
https://www.investing.com/news/analyst-ratings/morgan-stanley-raises-ftai-aviation-stock-price-target-on-growth-outlook-93CH-4576956
5
Investing.com News
https://www.investing.com/news/analyst-ratings/morgan-stanley-cuts-kyndryl-stock-price-target-on-ibm-relationship-concerns-93CH-4576957
6
Investing.com News
https://www.investing.com/news/stock-market-news/morgan-stanley-sees-us-industrial-sector-poised-to-benefit-from-reshoring-93CH-4577238
7
Yahoo Finance News
https://finance.yahoo.com/sectors/healthcare/articles/morgan-stanley-reiterates-overweight-eli-112719699.html
8
Investing.com News
https://www.investing.com/news/stock-market-news/asml-stock-morgan-stanley-flags-limited-nearterm-upside-4577366